AYX1: Completed Phase II enrollment

Adynxx completed enrollment of 120 patients in the double-blind, placebo-controlled, U.S. Phase II ADYX003 trial evaluating single intrathecal injections of 660 and 1,100 mg AYX1 given prior to unilat...